2016
DOI: 10.1177/0004563216680232
|View full text |Cite
|
Sign up to set email alerts
|

Clinical significance of GCF sIL-6R and calprotectin to evaluate the periodontal inflammation

Abstract: Background Periodontitis is an inflammatory disease. The aim of this study was to investigate whether the soluble form of interleukin-6 receptor (sIL-6R) and calprotectin concentrations in gingival crevicular fluid are useful biomarkers in the evaluation of periodontitis. Methods First, a cross-sectional study was performed. A total of 34 periodontitis patients were enrolled and the gingival crevicular fluid samples were collected from the healthy and inflamed sites of periodontal pockets in each patient. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
24
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 18 publications
(26 citation statements)
references
References 26 publications
2
24
0
Order By: Relevance
“…The present study demonstrated that calprotectin amounts and concentrations in PICF samples were significantly higher from diseased sites than from healthy sites, and a positive association was observed between calprotectin levels and clinical indicators such as PD and GI scores. This result for peri-implant diseases was similar to previous findings obtained in diagnostic studies on periodontal diseases [ 16 , 33 ]. A significant difference was noted in calprotectin amounts between GI-0 group and GI-1 or GI-2 group, suggesting that PICF calprotectin indicates initial, weak inflammation in peri-implant diseases because calprotectin is mainly existed in leukocytes that more express at early stage of inflammation and acute inflammation [ 14 , 15 ].…”
Section: Discussionsupporting
confidence: 91%
“…The present study demonstrated that calprotectin amounts and concentrations in PICF samples were significantly higher from diseased sites than from healthy sites, and a positive association was observed between calprotectin levels and clinical indicators such as PD and GI scores. This result for peri-implant diseases was similar to previous findings obtained in diagnostic studies on periodontal diseases [ 16 , 33 ]. A significant difference was noted in calprotectin amounts between GI-0 group and GI-1 or GI-2 group, suggesting that PICF calprotectin indicates initial, weak inflammation in peri-implant diseases because calprotectin is mainly existed in leukocytes that more express at early stage of inflammation and acute inflammation [ 14 , 15 ].…”
Section: Discussionsupporting
confidence: 91%
“…Furthermore, we showed previously that IL-6 binding to HGFs increases significantly in the presence of sIL-6R [20]. Considering the possible source of sIL-6R in periodontitis lesions, we reported that sIL-6R production was induced by IL-6 and CPT in THP-1 macrophages [7,21]. Importantly, we showed that CPT-mediated induction of sIL-6R inhibited significantly in THP-1 macrophages by TACE specific inhibitor, TAPI-1 (Fig.…”
Section: Discussionmentioning
confidence: 51%
“…A soluble form of interleukin 6 receptor (sIL-6R), known as an IL-6 agonist, is released by proteolytic cleavage from cell surface of immune/inflammatory cells such as lymphocytes and macrophages [6]. Our recent findings showed that sIL-6R levels in gingival crevicular fluid (GCF) of inflamed sites are significantly higher than in the healthy sites in periodontitis patients [7]. Importantly, it has been reported that both IL-1β and IL-6 levels in GCF were significantly elevated in diabetic patients [8,9].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations